Daxor Debt to Equity Ratio 2010-2011 | DXR

Current and historical debt to equity ratio values for Daxor (DXR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Daxor debt/equity for the three months ending December 31, 2011 was 0.00.
Daxor Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2011-12-31 $0.05B $0.04B 1.37
2011-09-30 $0.05B $0.04B 1.35
2011-06-30 $0.05B $0.05B 1.11
2011-03-31 $0.05B $0.05B 1.01
2010-12-31 $0.04B $0.05B 0.94
2010-09-30 $0.04B $0.05B 0.79
2010-06-30 $0.04B $0.04B 0.86
2010-03-31 $0.04B $0.05B 0.87
2009-12-31 $0.03B $0.05B 0.58
2009-09-30 $0.03B $0.05B 0.58
2009-06-30 $0.03B $0.05B 0.66
2009-03-31 $0.03B $0.03B 0.95
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.162B 10.99
Quest Diagnostics (DGX) United States $16.508B 17.06
DaVita (DVA) United States $12.078B 15.00
Encompass Health (EHC) United States $8.774B 22.46
Chemed (CHE) United States $8.268B 25.63
Elanco Animal Health (ELAN) United States $6.548B 16.99
Option Care Health (OPCH) United States $5.428B 20.55
RadNet (RDNT) United States $4.814B 100.25
Amedisys (AMED) United States $3.194B 22.62
Astrana Health (ASTH) United States $2.853B 38.60
Addus HomeCare (ADUS) United States $2.223B 28.77
LifeStance Health (LFST) United States $2.164B 0.00
U.S Physical Therapy (USPH) United States $1.487B 39.79
Pennant (PNTG) United States $0.823B 43.48
Aveanna Healthcare Holdings (AVAH) United States $0.708B 0.00
Atai Life Sciences (ATAI) Germany $0.275B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00